Tokyo, Nov. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059663) titled 'Evaluation of Urinary Metabolites Following Intake of a Test Food in Women with Normal Menstrual Cycles: A Single-Arm Pre-Post Comparison Study' on Nov. 6.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Ezaki Glico Co., Ltd.

Condition: Condition - Healthy Adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Establishment of an analytical method for urinary metabolites following consumption of the test food Basic objectives2 - Others

Intervention: Interventions/Control_1 - 8-day intake of test food

Eligibility: Age-lower limit - 18 years-old = Gender - Female Key inclusion criteria - (1)Japanese women residing in Japan who are between the ages of 18 and 40 at the time of obtaining consent to participate in the trial. (2)Individuals with a normal menstrual cycle (the last three menstrual cycles were between 25 and 38 days, and the duration of menstruation was between 3 and 7 days). (3)Individuals who can cooperate in consuming the test food daily during the intake period. (4)Individuals who have received sufficient explanation about the purpose and content of this study, possess the capacity to consent, can fully understand the content, and can provide written informed consent. Key exclusion criteria - (1) Regular use of oral contraceptives, ovulation inhibitors, hormonal drugs, or medicines/Kampo for menstrual symptoms (except temporary use of OTC analgesics for menstrual pain or headache, or laxatives/antidiarrheals around menstruation). (2) Under treatment for PMS, PMDD, dysmenorrhea, or other gynecological diseases (e.g., menopausal disorder, hormone therapy, uterine/ovarian/breast disease), or scheduled for such treatment during the study. (3) Under treatment for thyroid disease, autonomic disorders, psychiatric disorders (e.g., depression, anxiety, insomnia, panic disorder), diabetes, or hyperlipidemia, or scheduled for such treatment. (4) Under treatment for chronic diseases (e.g., anemia, perennial allergy, asthma, hypertension). (5) History of cerebrovascular, cardiac, hepatic, or renal disease. (6) History of major gastrointestinal surgery (e.g., gastrectomy, intestinal resection; appendectomy not excluded). (7) Allergy to the test food. (8) Pregnant, lactating, possibly pregnant, or planning pregnancy. (9) Regular use of FOSHU, Foods with Function Claims, health foods, or supplements with specific ingredients. (10) Unable to discontinue such foods or supplements during the study. (11) Unwilling to restrict intake of general foods high in specific ingredients during the study. (12) Heavy smokers (about 21+ cigarettes/day). (13) Habitual alcohol intake >=20 g/day (approx. 180 mL sake, 500 mL beer, 110 mL shochu, or 200 mL wine). (14) Extremely irregular sleep or diet (e.g., shift/night workers). (15) Regular use of antibiotics during the study. (16) Expected major changes in living environment, diet, or exercise during the study. (17) Judged by the investigator as inappropriate. Target Size - 10

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 10 Month 21 Day Date of IRB - 2025 Year 10 Month 21 Day Anticipated trial start date - 2025 Year 11 Month 07 Day Last follow-up date - 2026 Year 02 Month 28 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068228

Disclaimer: Curated by HT Syndication.